Edwards Lifesciences: Heart Valve Diseases trials

The registry lists 12 Heart Valve Diseases studies with Edwards Lifesciences as lead sponsor. 3 are open to participants now and 4 have results posted.

No phase 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The CLASP III TR CED StudyNot yet recruitingNCT07859709
• TRIFORMIS RESILIA Real-world Study Assessing Safety and Performance (TRIBLAZE Study)RecruitingNCT07684313
• Real World European Investigation of Safety and Clinical Efficacy of the EVOQUE System (TRISCEND III EU)RecruitingNCT06569602
• 2019-06 TRISCEND StudyActive, not recruitingNCT04221490Not applicableResults posted
• TRI-REPAIR: TrIcuspid Regurgitation RePAIr With CaRdioband Transcatheter SystemCompletedNCT02981953Not applicableResults posted
• REPAIR - transcatheteR rEPair of mitrAl Insufficiency With caRdioband SystemTerminatedNCT02703311Not applicableResults posted
• Magna Mitral - 23mmCompletedNCT01312779Not applicableResults posted
• J-Valve TF Early Feasibility StudyActive, not recruitingNCT06034028Not applicable
• TRISCEND JAPAN StudyActive, not recruitingNCT05760989Not applicable
• TRISCEND II Pivotal TrialActive, not recruitingNCT04482062Not applicable
• Early Feasibility Study of the CardiAQ™ TMVI System (Transfemoral and Transapical DS)WithdrawnNCT02515539Not applicable
• A Clinical Study of the CardiAQ™ TMVI System (Transapical DS)TerminatedNCT02478008Not applicable